NRX Pharmaceuticals
- Pharmaceutical Preparations
- Wilmington, Delaware
Compensation history
Top executives at NRX Pharmaceuticals received an average of $899K per person in annual compensation from 2020 to 2023.
Average pay of disclosed executives at NRX Pharmaceuticals
By year
- 2022
IS$1MIra StrassbergFormer Chief Financial Officer and TreasurerJJ$874KJonathan JavittChief Scientist and former Chief Executive OfficerSW$800KStephen H. WillardChief Executive OfficerRB$651KRobert BesthofFormer Chief Commercial and former Interim Chief Executive OfficerAD$585KAlessandra DaigneaultFormer Chief Corporate Officer, General Counsel and SecretarySV$355KSeth Van VoorheesFormer Chief Financial Officer and TreasurerRP$240KRiccardo PanicucciCMC and Technical Operations Advisor- 2021
RG$4MRandy GuggenheimerChief Business OfficerAD$2MAlessandra DaigneaultChief Corporate Officer, General Counsel and SecretaryJJ$377KJonathan JavittDirector and Former Chief Executive OfficerRB$264KRobert BesthofChief Commercial and Patient Officer and Head of Operations and Interim Chief Executive Officer
Executives
We found nine executives who work or worked at NRX Pharmaceuticals.
Stephen Willard
NRX Pharmaceuticals
Chief Executive Officer
Jonathan Javitt
NRX Pharmaceuticals
Chairman
Richard Narido
NRX Pharmaceuticals
Chief Financial Officer
Robert Besthof
NRX Pharmaceuticals
Chief Executive Officer
Seth Van Voorhees
NRX Pharmaceuticals
Chief Financial Officer
Riccardo Panicucci
NRX Pharmaceuticals
CMC and Technical Operations Advisor
Ira Strassberg
NRX Pharmaceuticals
Chief Financial Officer
Alessandra Daigneault
NRX Pharmaceuticals
General Counsel
News
About NRX Pharmaceuticals
- Industry classifications
- DivisionManufacturing
- Major groupChemicals And Allied Products
- Industry groupDrugs
- IndustryPharmaceutical Preparations
- Address1201 Orange Street, Suite 600, Wilmington, Delaware 19801
- Phone484-254-6134
- Fiscal year endDecember 31
- Former names
- Big Rock Partners Acquisition Corp.Until May 23, 2021
Source: SEC filings on September 5, 2024, November 22, 2023, and June 17, 2022.